Lundbeckfond Ventures (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:
Copenhagen
Average round investment:
23.68M USD

Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.

Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

We tracked 8 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures mostly invests with:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Lundbeckfond Ventures:

InvestorCriteria
Denmark Sunstone Life Science Ventures
68%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1
  • Active last 12 months: Yes
Index Ventures
60%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2
  • Active last 12 months: Yes
Sweden Karolinska Development
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Norway Ferd Capital
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
LSP (Life Sciences Partners)
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Denmark Novo Seeds
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.5
Norway Sarsia Seed Management
48%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.7
Summit Partners
46%
  • Range for average deal size: 20M - 50M USD
  • Similar business models: B2B
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Finland Juuri Partners
46%
  • Range for average deal size: 20M - 50M USD
  • Similar business models: B2B
  • Average number of deals per year: 2
  • Active last 12 months: Yes
Finland Finnvera
46%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 5.4
  • Active last 12 months: Yes

News about Lundbeckfond Ventures

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)